US Equity
ASND
— Ascendis Pharma A/SAscendis Pharma A/S is a biotechnology company focused on discovering and developing innovative therapies and treatments for serious diseases.
💰 Market cap: $16.77B📍 Tuborg Boulevard 12, HELLERUP, CAPITAL REGION OF DENMARK, 2900 DK🏷️ Biotechnology & Medical Research💵 Previous close: $253.86🔢 4,694 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $253.86 |
| 2026-07-23 | $252.66 |
| 2026-07-22 | $251.93 |
| 2026-07-21 | $255.20 |
| 2026-07-20 | $251.76 |
| 2026-07-17 | $261.00 |
| 2026-07-16 | $259.80 |
| 2026-07-15 | $268.57 |
| 2026-07-14 | $265.57 |
| 2026-07-13 | $265.22 |
| 2026-07-10 | $270.45 |
| 2026-07-09 | $275.43 |
| 2026-07-08 | $277.18 |
| 2026-07-07 | $266.97 |
| 2026-07-06 | $267.92 |
| 2026-07-02 | $274.50 |
| 2026-07-01 | $267.79 |
| 2026-06-30 | $266.72 |
| 2026-06-29 | $263.70 |
| 2026-06-26 | $260.75 |
| 2026-06-25 | $261.58 |
| 2026-06-24 | $238.01 |
| 2026-06-23 | $238.59 |
| 2026-06-22 | $228.00 |
| 2026-06-18 | $230.83 |
| 2026-06-17 | $231.15 |
| 2026-06-16 | $231.20 |
| 2026-06-15 | $223.29 |
| 2026-06-12 | $218.06 |
| 2026-06-11 | $215.60 |
| 2026-06-10 | $209.79 |
| 2026-06-09 | $213.23 |
| 2026-06-08 | $205.81 |
| 2026-06-05 | $210.45 |
| 2026-06-04 | $218.84 |
| 2026-06-03 | $216.79 |
| 2026-06-02 | $216.60 |
| 2026-06-01 | $218.82 |
| 2026-05-29 | $224.11 |
| 2026-05-28 | $237.47 |
| 2026-05-27 | $235.26 |
| 2026-05-26 | $239.65 |
| 2026-05-22 | $247.05 |
| 2026-05-21 | $247.51 |
| 2026-05-20 | $241.34 |
| 2026-05-19 | $237.98 |
| 2026-05-18 | $237.64 |
| 2026-05-15 | $240.50 |
| 2026-05-14 | $245.49 |
| 2026-05-13 | $243.58 |
| 2026-05-12 | $237.65 |
| 2026-05-11 | $238.67 |
| 2026-05-08 | $238.66 |
| 2026-05-07 | $246.14 |
| 2026-05-06 | $235.90 |
| 2026-05-05 | $225.28 |
| 2026-05-04 | $228.71 |
| 2026-05-01 | $220.93 |
| 2026-04-30 | $229.38 |
| 2026-04-29 | $220.28 |
| 2026-04-28 | $222.08 |